Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001628280-25-023291
Filing Date
2025-05-08
Accepted
2025-05-07 17:33:28
Documents
71
Period of Report
2025-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q vir-20250331.htm   iXBRL 10-Q 1065151
2 EX-10.2 a20250331-q1ex102amendedan.htm EX-10.2 422556
3 EX-31.1 a20250331-q110qex311.htm EX-31.1 10930
4 EX-31.2 a20250331-q110qex312.htm EX-31.2 11168
5 EX-32.1 a20250331-q110qex321.htm EX-32.1 8402
  Complete submission text file 0001628280-25-023291.txt   6122158

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT vir-20250331.xsd EX-101.SCH 46163
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT vir-20250331_cal.xml EX-101.CAL 73381
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT vir-20250331_def.xml EX-101.DEF 193887
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT vir-20250331_lab.xml EX-101.LAB 560020
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT vir-20250331_pre.xml EX-101.PRE 381248
74 EXTRACTED XBRL INSTANCE DOCUMENT vir-20250331_htm.xml XML 561511
Mailing Address 1800 OWENS STREET SUITE 900 SAN FRANCISCO CA 94158
Business Address 1800 OWENS STREET SUITE 900 SAN FRANCISCO CA 94158 415-906-4324
Vir Biotechnology, Inc. (Filer) CIK: 0001706431 (see all company filings)

EIN.: 812730369 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39083 | Film No.: 25923030
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)